An esophageal mass with coexistent Mycobacterium chelonae and Candida albicans infections in an immunocompetent adult.
Mycobacteria chelonae was originally included in group IV of Runyon's classification of atypical mycobacteria. This rapidly growing environmental organism often caused infections in immunocompromised hosts. Candida albicans is a ubiquitous micro-organism and frequently isolated from the gastrointestinal tract. These two micro-organisms seldom cause esophageal diseases in healthy humans. We report a case of a fruit farmer with a submucosa tumor of distal esophagus caused by coexistence of M. chelonae and C. albicans infections, which was successfully treated by surgical resection and following antimicrobial regimens postoperatively.
Hsu
Hsao-Hsun
HH
Department of Surgery, National Taiwan University Hospital, College of Medicine, No. 7, Chung-Shan South Road, Taipei, Taiwan, ROC.
Chang
Yih-Leong
YL
Chen
Jin-Shing
JS
Hsueh
Po-Ren
PR
Lee
Yung-Chie
YC
D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000175:diagnosis*; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D007121:Immunocompetence; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D016926:Mycobacterium chelonae / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D015378:Imipenem; D000583:Amikacin; D015725:Fluconazole